BARCELONA, Spain--(BUSINESS WIRE)--INBRAIN Neuroelectronics, a brain-computer interface therapeutics (BCI-Tx) company pioneering graphene-based neural technologies, announced today the world’s first ...

VC funding led by imec.xpand, with significant participation from the EIC Fund (venture arm of the European Innovation Council) and continued support from existing investors Asabys Partners and Aliath ...

Inbrain Neuroelectronics signed a pact with Microsoft to use the tech giant’s Azure AI infrastructure to advance the Spanish company’s graphene-based brain-computer interface (BCI) technology. Inbrain ...

Image caption: INBRAIN Cortical BCI; Image credit: INBRAIN Neuroelectronics Graphene-based BCI demonstrates high-resolution brain decoding and mapping in patients undergoing tumor resection at the ...

INBRAIN Neuroelectronics, a brain-computer interface therapeutics (BCI-Tx) company developing graphene-based neural technologies, today announced the appointment of Scott Huennekens as Chairman of its ...

InBrain Neuroelectronics has won a €4m ($4.5m) grant from the Spanish Ministry of Industry and Tourism to develop its brain-computer interface (BCI) platform technology. InBrain’s BCI is made of ...

Barcelona-based INBRAIN Neuroelectronics, which offers a graphene-based brain-computer interface (BCI) therapeutics platform, announced a strategic partnership with tech giant Microsoft to advance the ...

INBRAIN Neuroelectronics, a brain-computer interface therapeutics (BCI-Tx) company developing graphene-based neural technologies, today announced a strategic collaboration with Microsoft to explore ...

Barcelona-based InBrain Neuroelectronics shared interim findings from a first-in-human clinical study of its graphene-based brain-computer interface (BCI) technology. InBrain says its technology ...

InBrain Neuroelectronics has partnered with Microsoft to explore how it can advance precision neurology by applying agentic AI to its brain computer-interface (BCI) platform. The strategic partnership ...

Lille, May 12, 2025 - InBrain Pharma, a clinical stage biotech specialized in therapeutic solution development against neurodegenerative diseases, is thrilled to announce that it has been selected as ...